The latest PHA Classroom video series, “Treating Pulmonary Hypertension,” explores treatment pathways. In the six-part series, pulmonologist Christopher King from Inova Fairfax Hospital explains how changes in body chemistry — or pathways — cause cells and organs to react abnormally.
The videos addresses how abnormalities in four chemical families or pathways contribute to PH by causing the blood vessels in the lungs to tighten. In the videos, King explains pulmonary vasodilator medications, specific pathways to treat PH, combination therapy benefits and elements of treatment plans.
Discover the new videos
Treating Pulmonary Hypertension: Pulmonary Vasodilator Medications
Pulmonary vasodilator medications dilate blood vessels in the lungs to improve circulation. But they are just one element of your treatment plan. Learn about these medications and other factors that contribute to your care plan.
Treating Pulmonary Hypertension: the Endothelin Pathway
Discover how medications in this drug class help blood vessels relax, reduce symptoms and support daily activities for people living with PH.
Treating Pulmonary Hypertension: the Activin-Signaling Pathway
Learn how activin-signaling medications can help restore balance, improve blood flow and support healthier blood vessels.
Treating Pulmonary Hypertension: the Nitric Oxide Pathway
Learn how medications that target the nitric oxide pathway help to widen blood vessels in the lungs and improve blood flow.
Treating Pulmonary Hypertension: the Prostacyclin Pathway
Learn how prostacyclin-based treatments work to widen blood vessels and support lung health.
Treating Pulmonary Hypertension: Creating a Plan That’s Right for You
Combination therapy is a key element of many PH care plans. Find out the benefits of taking two or more medications that target different pathways, how combination therapy works and how it relates to other aspects of your treatment plan.
Categories: